Abstract
BACKGROUND: The concentration of nitric oxide (NO) is increased in the exhaled air of patients with inflammation of the airways, suggesting that this may be a useful measurement to monitor inflammation in diseases such as asthma. However, there have been concerns that exhaled NO may be contaminated by the high concentrations of NO derived from the upper airways, and that this may account for differences in reported values of exhaled NO using different techniques. A study was performed, with argon as a tracer, to determine the extent of nasal contamination of exhaled NO using different expiratory manoeuvres. METHODS: Exhaled and nasal NO were measured by a chemiluminescence analyser. Argon (4.8%) was delivered continuously to the nose. Gas was sampled from the posterior oropharynx and argon and carbon dioxide were measured by mass spectrometry at the same time as NO. RESULTS: During a single expiration against a low resistance and during breath holding there was no evidence for nasal contamination, whereas during exhalation without resistance argon concentration in the oropharynx was increased from 0.91% (95% CI 0.84% to 0.98%) in ambient air to 1.28% (0.9% to 2.24%, p < 0.0001) during a single breath or 2.37% (2.29% to 2.51%, p < 0.0001) during tidal breathing. CONCLUSIONS: Collection of exhaled NO in a reservoir during tidal breathing is likely to be contaminated by NO derived from the nose and this may underestimate any increases in NO derived from the lower respiratory tract in inflammatory diseases. However, with slow expiration against a resistance and created back pressure to close the soft palate, there is no contamination of exhaled air which then reflects concentrations of NO in the lower airways.
Full Text
The Full Text of this article is available as a PDF (147.6 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Barnes P. J. NO or no NO in asthma? Thorax. 1996 Feb;51(2):218–220. doi: 10.1136/thx.51.2.218. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Barnes P. J. Nitric oxide and airway disease. Ann Med. 1995 Jun;27(3):389–393. doi: 10.3109/07853899509002592. [DOI] [PubMed] [Google Scholar]
- Borland C., Cox Y., Higenbottam T. Measurement of exhaled nitric oxide in man. Thorax. 1993 Nov;48(11):1160–1162. doi: 10.1136/thx.48.11.1160. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Cremona G., Higenbottam T., Takao M., Hall L., Bower E. A. Exhaled nitric oxide in isolated pig lungs. J Appl Physiol (1985) 1995 Jan;78(1):59–63. doi: 10.1152/jappl.1995.78.1.59. [DOI] [PubMed] [Google Scholar]
- Gerlach H., Rossaint R., Pappert D., Knorr M., Falke K. J. Autoinhalation of nitric oxide after endogenous synthesis in nasopharynx. Lancet. 1994 Feb 26;343(8896):518–519. doi: 10.1016/s0140-6736(94)91465-6. [DOI] [PubMed] [Google Scholar]
- Kharitonov S. A., Chung K. F., Evans D., O'Connor B. J., Barnes P. J. Increased exhaled nitric oxide in asthma is mainly derived from the lower respiratory tract. Am J Respir Crit Care Med. 1996 Jun;153(6 Pt 1):1773–1780. doi: 10.1164/ajrccm.153.6.8665033. [DOI] [PubMed] [Google Scholar]
- Kharitonov S. A., Wells A. U., O'Connor B. J., Cole P. J., Hansell D. M., Logan-Sinclair R. B., Barnes P. J. Elevated levels of exhaled nitric oxide in bronchiectasis. Am J Respir Crit Care Med. 1995 Jun;151(6):1889–1893. doi: 10.1164/ajrccm.151.6.7767536. [DOI] [PubMed] [Google Scholar]
- Kharitonov S. A., Yates D. H., Barnes P. J. Inhaled glucocorticoids decrease nitric oxide in exhaled air of asthmatic patients. Am J Respir Crit Care Med. 1996 Jan;153(1):454–457. doi: 10.1164/ajrccm.153.1.8542158. [DOI] [PubMed] [Google Scholar]
- Kharitonov S. A., Yates D. H., Chung K. F., Barnes P. J. Changes in the dose of inhaled steroid affect exhaled nitric oxide levels in asthmatic patients. Eur Respir J. 1996 Feb;9(2):196–201. doi: 10.1183/09031936.96.09020196. [DOI] [PubMed] [Google Scholar]
- Kharitonov S. A., Yates D., Barnes P. J. Increased nitric oxide in exhaled air of normal human subjects with upper respiratory tract infections. Eur Respir J. 1995 Feb;8(2):295–297. doi: 10.1183/09031936.95.08020295. [DOI] [PubMed] [Google Scholar]
- Kimberly B., Nejadnik B., Giraud G. D., Holden W. E. Nasal contribution to exhaled nitric oxide at rest and during breathholding in humans. Am J Respir Crit Care Med. 1996 Feb;153(2):829–836. doi: 10.1164/ajrccm.153.2.8564139. [DOI] [PubMed] [Google Scholar]
- Leone A. M., Gustafsson L. E., Francis P. L., Persson M. G., Wiklund N. P., Moncada S. Nitric oxide is present in exhaled breath in humans: direct GC-MS confirmation. Biochem Biophys Res Commun. 1994 Jun 15;201(2):883–887. doi: 10.1006/bbrc.1994.1784. [DOI] [PubMed] [Google Scholar]
- Massaro A. F., Gaston B., Kita D., Fanta C., Stamler J. S., Drazen J. M. Expired nitric oxide levels during treatment of acute asthma. Am J Respir Crit Care Med. 1995 Aug;152(2):800–803. doi: 10.1164/ajrccm.152.2.7633745. [DOI] [PubMed] [Google Scholar]
- Massaro A. F., Mehta S., Lilly C. M., Kobzik L., Reilly J. J., Drazen J. M. Elevated nitric oxide concentrations in isolated lower airway gas of asthmatic subjects. Am J Respir Crit Care Med. 1996 May;153(5):1510–1514. doi: 10.1164/ajrccm.153.5.8630594. [DOI] [PubMed] [Google Scholar]
- Persson M. G., Wiklund N. P., Gustafsson L. E. Endogenous nitric oxide in single exhalations and the change during exercise. Am Rev Respir Dis. 1993 Nov;148(5):1210–1214. doi: 10.1164/ajrccm/148.5.1210. [DOI] [PubMed] [Google Scholar]
- Persson M. G., Zetterström O., Agrenius V., Ihre E., Gustafsson L. E. Single-breath nitric oxide measurements in asthmatic patients and smokers. Lancet. 1994 Jan 15;343(8890):146–147. doi: 10.1016/s0140-6736(94)90935-0. [DOI] [PubMed] [Google Scholar]
- Robbins R. A., Floreani A. A., Von Essen S. G., Sisson J. H., Hill G. E., Rubinstein I., Townley R. G. Measurement of exhaled nitric oxide by three different techniques. Am J Respir Crit Care Med. 1996 May;153(5):1631–1635. doi: 10.1164/ajrccm.153.5.8630613. [DOI] [PubMed] [Google Scholar]
- Schilling J., Holzer P., Guggenbach M., Gyurech D., Marathia K., Geroulanos S. Reduced endogenous nitric oxide in the exhaled air of smokers and hypertensives. Eur Respir J. 1994 Mar;7(3):467–471. doi: 10.1183/09031936.94.07030467. [DOI] [PubMed] [Google Scholar]
- Yates D. H., Kharitonov S. A., Robbins R. A., Thomas P. S., Barnes P. J. Effect of a nitric oxide synthase inhibitor and a glucocorticosteroid on exhaled nitric oxide. Am J Respir Crit Care Med. 1995 Sep;152(3):892–896. doi: 10.1164/ajrccm.152.3.7663801. [DOI] [PubMed] [Google Scholar]